OMONTYS PRESERVATIVE FREE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Omontys Preservative Free, and when can generic versions of Omontys Preservative Free launch?
Omontys Preservative Free is a drug marketed by Takeda Pharms Usa and is included in one NDA. There are six patents protecting this drug.
This drug has one hundred and fourteen patent family members in thirty-four countries.
The generic ingredient in OMONTYS PRESERVATIVE FREE is peginesatide acetate. Additional details are available on the peginesatide acetate profile page.
DrugPatentWatch® Generic Entry Outlook for Omontys Preservative Free
Omontys Preservative Free was eligible for patent challenges on March 27, 2016.
Indicators of Generic Entry
Summary for OMONTYS PRESERVATIVE FREE
International Patents: | 114 |
US Patents: | 6 |
Applicants: | 1 |
NDAs: | 1 |
Formulation / Manufacturing: | see details |
DailyMed Link: | OMONTYS PRESERVATIVE FREE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for OMONTYS PRESERVATIVE FREE
US Patents and Regulatory Information for OMONTYS PRESERVATIVE FREE
OMONTYS PRESERVATIVE FREE is protected by six US patents.
Patents protecting OMONTYS PRESERVATIVE FREE
Peptides that bind to the erythropoietin receptor
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ANEMIA DUE TO CHRONIC KIDNEY DISEASE
Peptides that bind to the erythropoietin receptor
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ANEMIA DUE TO CHRONIC KIDNEY DISEASE
Peptides that bind to the erythropoietin receptor
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Erythropoietin receptor peptide formulations and uses
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ANEMIA DUE TO CHRONIC KIDNEY DISEASE
Spacer moiety for poly (ethylene glycol) modified peptide based compounds
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Erythropoietin receptor peptide formulations and uses
Patent Number: ⤷ Try a Trial
Patent Expiration: ⤷ Try a Trial
Patented Use: TREATMENT OF ANEMIA DUE TO CHRONIC KIDNEY DISEASE
International Patents for OMONTYS PRESERVATIVE FREE
See the table below for patents covering OMONTYS PRESERVATIVE FREE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Australia | 2004238868 | Peptides that bind to the erythropoietin receptor | ⤷ Try a Trial |
South Korea | 20060022239 | NOVEL PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR | ⤷ Try a Trial |
Japan | 2009108061 | NEW PEPTIDE THAT BINDS TO ERYTHROPOIETIN RECEPTOR | ⤷ Try a Trial |
South Korea | 20120094001 | PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR | ⤷ Try a Trial |
Japan | 4768795 | ⤷ Try a Trial | |
Hong Kong | 1088616 | NOVEL PEPTIDES THAT BIND TO THE ERYTHROPOIETIN RECEPTOR | ⤷ Try a Trial |
Costa Rica | 9570 | FORMULACIONES Y USOS DEL PEPTIDO RECEPTOR DE ERITROPOYETINA | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |